Caption Management’s NovoCure NVCR Stock Holding History

Caption Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,493	Closed	-$39K	–	1402
2024 Q1	$39K	Buy	+2,493	New	+$36.7K	﹤0.01%	1095
2023 Q3	–	Sell	-801	Closed	-$23.1K	–	1444
2023 Q2	$33.2K	Sell	801 -30,132	-97%	-$1.87M	﹤0.01%	1021
2023 Q1	$1.86M	Buy	+30,933	New	+$2.47M	0.04%	457
2022 Q1	–	Sell	-794	Closed	-$58.5K	–	1783
2021 Q4	$60K	Buy	+794	New	+$79.7K	﹤0.01%	1503
2021 Q1	–	Sell	-55,400	Closed	-$8.76M	–	1286
2020 Q4	$9.59M	Buy	55,400 +34,400	+164%	+$4.71M	0.22%	126
2020 Q3	$2.34M	Buy	+21,000	New	+$1.68M	0.05%	382

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Caption Management's NVCR Position: Q2 2024 in Review

Caption Management sold out of NovoCure (NVCR) in Q2 2024, closing a stake of 2,493 shares — an estimated $39K sold.

Caption Management first reported a position in NVCR in Q3 2020 and held it in 6 quarters. The position peaked at $9.59M in Q4 2020. 237 funds tracked by Wall St. Rank hold NVCR as of Q2 2024.

Caption Management reported no remaining NovoCure position as of Q2 2024 after selling out during the quarter.
Caption Management sold 2,493 NovoCure shares in Q2 2024, an estimated $39K.
Caption Management first reported a position in NovoCure in Q3 2020 and held it in 6 quarters.
Caption Management's NovoCure position peaked at $9.59M in Q4 2020.
237 funds tracked by Wall St. Rank held NovoCure as of Q2 2024.

Based on Caption Management's 13F filing for Q2 2024, filed 14 Aug 2024.